NIH announces phase III clinical trial of creatine for Parkinson's disease.
Bloom
Marlene Z
MZ
D017326:Clinical Trials, Phase III as Topic; D003401:Creatine / Q000627:therapeutic use*; D019587:Dietary Supplements; D006801:Humans; D009316:National Institutes of Health (U.S.); D010300:Parkinson Disease / Q000188:drug therapy*; D014481:United States
D003401:Creatine